Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy episode artwork

EPISODE · May 14, 2025 · 29 MIN

Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

from Immunity Group Podcast · host Immunity Group Australia

In this episode of the Immunity Group Australia Podcast, leading pediatric allergist Dr. Jose Costa shares how early allergen introduction, personalized care, and innovative immunotherapy protocols are transforming the way we treat allergies.Dr. Costa opens up about his journey into allergy medicine and explains the science behind oral immunotherapy (OIT)—a treatment approach giving hope to families dealing with severe food allergies. He also discusses promising research using omalizumab (Xolair) to enhance OIT outcomes and why the UK is a critical next step in expanding access to care.Learn how airborne allergen immunotherapy could help reduce food allergies, asthma, and eczema, and why outdated advice on allergen avoidance may be causing more harm than good. Dr. Costa's vision challenges the status quo and offers a new path forward for clinicians, parents, and allergy sufferers alike.

Episode metadata supplied by the publisher feed · Published May 14, 2025

Embed this episode

NOW PLAYING

Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

0:00 29:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Immunity Group Podcast?

This episode is 29 minutes long.

When was this Immunity Group Podcast episode published?

This episode was published on May 14, 2025.

Can I download this Immunity Group Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!